25 Jan Placental Growth Factor: New treatment target bringing hope in hepatopulmonary syndrome. Published in Hepatology 2018
Invited Editorial, by Mercedes Fernandez, published in Hepatology 2018. Devoted to the study by Raevens et al. Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice. Hepatology. 2017 Oct 10. doi: 10.1002/hep.29579.